Paper42007253
Artificial intelligence-based prognostic models in acute myeloid leukemia: systematic review and meta-analysis.
Zhang X and 8 others. Blood Neoplasia, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Artificial intelligence-based prognostic models in acute myeloid leukemia: systematic review and meta-analysis. Papers, record 42007253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Artificial intelligence-based prognostic models in acute myeloid leukemia: systematic review and meta-analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38322112 | Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid Leukemia Reveals a Signature Predicting Survival and Immunotherapy. | Int J Clin Pract | 2024 | https://conductscience.org/library/papers/38322112 | PubMed |
| 2 | 36757706 | Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial. | JAMA Oncol | 2023 | https://conductscience.org/library/papers/36757706 | PubMed |
| 3 | 39215200 | Machine learning in paediatric haematological malignancies: a systematic review of prognosis, toxicity and treatment response models. | Pediatr Res | 2025 | https://conductscience.org/library/papers/39215200 | PubMed |
| 4 | 39941850 | Machine Learning Methods in Clinical Flow Cytometry. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941850 | PubMed |
| 5 | 29506270 | Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia. | J Natl Cancer Inst | 2018 | https://conductscience.org/library/papers/29506270 | PubMed |
| 6 | 36130297 | Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. | Blood | 2022 | https://conductscience.org/library/papers/36130297 | PubMed |
| 7 | 36902217 | Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902217 | PubMed |
| 8 | 35522898 | Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation. | JCO Clin Cancer Inform | 2022 | https://conductscience.org/library/papers/35522898 | PubMed |
| 9 | 38215555 | Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study. | Leuk Res | 2024 | https://conductscience.org/library/papers/38215555 | PubMed |
| 10 | 34229733 | Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement. | J Hematol Oncol | 2021 | https://conductscience.org/library/papers/34229733 | PubMed |
| 11 | 40068020 | Big data analytics and machine learning in hematology: Transformative insights, applications and challenges. | Medicine (Baltimore) | 2025 | https://conductscience.org/library/papers/40068020 | PubMed |
| 12 | 37621173 | Recent advances in precision medicine for acute myeloid leukemia. | Curr Opin Oncol | 2023 | https://conductscience.org/library/papers/37621173 | PubMed |
| 13 | 39373568 | High-dimensional Immune Profiles and Machine Learning May Predict Acute Myeloid Leukemia Relapse Early following Transplant. | J Immunol | 2024 | https://conductscience.org/library/papers/39373568 | PubMed |
| 14 | 36246561 | Five EMT-Related Gene Signatures Predict Acute Myeloid Leukemia Patient Outcome. | Dis Markers | 2022 | https://conductscience.org/library/papers/36246561 | PubMed |
| 15 | 35241089 | Survival prediction in acute myeloid leukemia using gene expression profiling. | BMC Med Inform Decis Mak | 2022 | https://conductscience.org/library/papers/35241089 | PubMed |
| 16 | 39897067 | Artificial intelligence for the detection of acute myeloid leukemia from microscopic blood images; a systematic review and meta-analysis. | Front Big Data | 2024 | https://conductscience.org/library/papers/39897067 | PubMed |
| 17 | 26343745 | Meta-analysis in clinical trials revisited. | Contemp Clin Trials | 2015 | https://conductscience.org/library/papers/26343745 | PubMed |
| 18 | 37497720 | AFEI: adaptive optimized vertical federated learning for heterogeneous multi-omics data integration. | Brief Bioinform | 2023 | https://conductscience.org/library/papers/37497720 | PubMed |
| 19 | 29242298 | A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia. | Haematologica | 2018 | https://conductscience.org/library/papers/29242298 | PubMed |
| 20 | 37253690 | Precision oncology: a review to assess interpretability in several explainable methods. | Brief Bioinform | 2023 | https://conductscience.org/library/papers/37253690 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42645891 | Artificial Intelligence for Personalized Management of Acute Myeloid Leukemia. | J Pers Med | 2026 | https://conductscience.org/library/papers/42645891 | PubMed |
| 42188361 | Evolving Management Approaches Toward Personalized Therapy in Acute Myeloid Leukemia: A Narrative Review. | J Pers Med | 2026 | https://conductscience.org/library/papers/42188361 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007253
GET https://conductscience.org/api/papers/v1/42007253/references?page=2